BROOKE JOHNSON: Open Payments
NPI 1932531316 · CLINTON, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$630 in 32 payments from 11 companies in 2025. Trend: 2023 $318 · 2024 $456 · 2025 $630
Food & beverage: $630
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $270 |
| AstraZeneca Pharmaceuticals LP | 3 | $60 |
| Novo Nordisk Inc | 3 | $55 |
| Amgen Inc. | 3 | $53 |
| Dexcom, Inc. | 2 | $50 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $46 |
| Lilly USA, LLC | 1 | $23 |
| Phathom Pharmaceuticals, Inc. | 1 | $22 |
| Alkermes, Inc. | 1 | $19 |
| Indivior Inc. | 1 | $17 |
Products named: VRAYLAR, BREZTRI, Dexcom G6 Transmitter, CAPLYTA, QULIPTA, Wegovy, REPATHA, MOUNJARO.
Industry payments across IA — which companies pay providers there.
